Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
-
-
Costco co-founder Jeff Brotman and Dan Baty donated $50 million to create the Brotman Baty Institute for Precision Medicine
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
-
Ozempic (semaglutide) was approved in the U.S.
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
-
First wine making was discovered
On. Nov. 30, 2017, research by Dr. Patrick McGovern, Director of the Biomolecular Archaeology Laboratory at the University…
-
Scientists Created First Semi-Synthetic Organism that Stored and Retrieved Unnatural Information
On Nov. 29, 2017, scientists at The Scripps Research Institute (TSRI) announced they had designed a bacterium with…
-
University of Washington surgeons performed region’s 1st ‘liver in a box’ transplant
On Nov. 27, 2017, surgeons at University of Washington Medicine in Seattle announced they had performed the first…
-
Disease | FDA | Therapeutics
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
-
Irving Family bequests $700 Million to Columbia and NewYork-Presbyterian for Cancer Research and Care
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
-
Wyss Medical Foundation pledged $2 million to support James P Stannard as Wyss Distinguished Chair of Orthopaedic Surgery
On Nov. 10, 2017, the Wyss Medical Foundation pledged $2 million to support James P. Stannard as the…
-
FDA licensed Heplisav-B, the new hepatitis B vaccine from Dynavax, for use in adults age 18 and older
On Nov. 9, 2017, Dynavax Technologies announced that the U.S. Food and Drug Administration (FDA) had approved HEPLISAV-B…
-
$13 million NIH grant to UNMC seeks to determine if vitamin D can produce infection-fighting peptide
On Nov. 9, 2017, University of Nebraska Medical Center (UNMC) announced that Jingwei Xie, Ph.D, a biomedical engineer,…
-
The Calgary Cancer Centre broke ground
On Nov. 3, 2017, construction started on the Calgary Cancer Centre located at the northeast corner of the…
-
Quest Diagnostics acquired Cleveland HeartLab
On Dec. 1, 2017, Quest Diagnostics announced it acquired Cleveland HeartLab, a leader in innovative diagnostic services for…
-
Biotechnology | Environmental | Genomics | Life Science History | Medicine | Non-Profit Research | Pharmaceutical
Earth Microbiome Project scientists announced unprecedented catalog of microbial life on planet Earth
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
-
Biotechnology | Disease | FDA | Vaccine
FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and older
On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…
-
Biotechnology | Disease | FDA | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in…
-
Biotechnology | NIH | Oncology
NIH partners with leading companies to accelerate development of cancer immunotherapies
On Oct. 12, 2017, The National Institutes of Health (NIH) and 11 biopharmaceutical companies recently announced the launch…
-
Biotechnology | Diagnostics | Genomics | Infectious Disease | NIH | Non-Profit Research | Therapeutics
NIH completed atlas of human DNA differences that influence gene expression
On Oct. 11, 2017, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
-
$13.4 million to build next-gen MRI brain scanner at UC Berkeley
On Oct. 6, 2017, UC Berkeley researchers announced they had developed reimagined fMRI techniques and instruments to boost…
-
Michael Rosbash was awarded 2017 Nobel Prize in Physiology or Medicine
On Oct. 2, 2017, The Nobel Assembly at the Karolinska Institute announced that Michael Rosbash, a Howard Hughes…
-
Biotechnology | Genomics | NIH | Oncology | Therapeutics
Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discovery
On Oct. 2, 2017, a research team led by Haian Fu, PhD, within the cancer genomics center at…
-
Emory University’s Center for Selective C-H Functionalization was awarded a $20 million grant by the NSF to advance organic synthesis
On Oct. 2, 2017, the National Science Foundation (NSF) announced it has awarded another $20 million to Emory…
-
Ground was broken for the MSU Grand Rapids Research Center
On Sept. 20, 2017, a new era of medical discovery began when ground was broken for the MSU…
-
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Therapeutics
deCODE study revealed an ancient achilles heel in the human genome
On Sept. 20, 2017, resarchers at deCODE genetics use whole-genome data from 14,000 people from across the population…
-
NIH expanded license agreement with Medigen Vaccines Biologics for Dengue vaccine from 17 to 26 countries
On Sept. 18, 2017, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
-
PATH announced a $120 million grant from the Bill & Melinda Gates Foundation
On Sept. 6, 2017, PATH announced it has received a $120 million grant from the Bill & Melinda…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approves personalized cellular therapy for advanced leukemia developed at Penn and CHOP
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved a personalized cellular therapy developed by…
-
Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes
On Aug. 28, 2017, a team of researchers led by the Yale School of Public Health announced they…
-
Biotechnology | CDC | Vaccine
AAP issued policy stating that newborns should routinely receive hepatitis B vaccine within 24 hours of birth
On Aug. 28, 2017, the American Academy of Pediatrics (AAP) issued policy stating that newborns should routinely receive…
